Orexo sues Sun Pharma over opioid dependence generic
16-09-2020
US judge dismisses attorney’s ‘opportunistic’ whistleblower suit
14-05-2020
Pavel Kapysh / Shutterstock.com
Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Bausch Health, Sun Pharma, generics, generic litigation, Xifaxan, antibiotics, ANDA, FDA, settlement
